Lee A-Jin, Bang Hae In, Lee Sun Min, Won Dongil, Kang Myung Seo, Choi Hyun-Ji, Lee In Hee, Jeon Chang-Ho
Department of Laboratory Medicine, Daegu Catholic University Medical Center, Daegu, Republic of Korea.
Department of Laboratory Medicine, Soonchunhyang University Seoul Hospital, Seoul, Republic of Korea.
J Clin Lab Anal. 2025 Mar;39(5):e25159. doi: 10.1002/jcla.25159. Epub 2025 Feb 3.
The clinical utility of urinary red blood cell (RBC) distribution (URD) remains limited. This study aimed to compare the diagnostic performance of URD and dysmorphic RBC (dRBC) in a multicenter study.
This study enrolled 703 patients who visited four tertiary medical centers in Korea. Patients were classified into glomerular diseases with biopsy (N = 169), renal diseases including chronic kidney disease (N = 194), nephrotic syndrome (NS; N = 88), tubulointerstitial diseases (N = 36), acute kidney injury (N = 32), others (N = 10), and extrarenal diseases (N = 174). Renal parameters, urine microscopic examination, urinalysis, and URD assessments were conducted. The diagnostic performances of dRBC and URD were evaluated.
Median values of both dRBC and URD were significantly elevated in patients with glomerular diseases. URD exhibited a significant correlation with dRBC (r = 0.536) and albumin creatinine ratio (r = 0.186), while no significant correlation was observed with specific gravity (r = -0.03). Among renal diseases, dRBC and URD values were notably higher in patients with NS. The agreement rate between dRBC and URD results was 78.3% (112/143), with 31 instances showing discrepancies. ROC curve analysis comparing glomerular and extrarenal diseases yielded cutoff values of 18% for dRBC and 31.9% for URD, resulting in corresponding areas under the curve (AUC) of 0.79 and 0.83, respectively.
URD exhibited a comparable diagnostic performance, as indicated by a similar AUC value to that of dRBC, while offering the added advantage of providing objective and standardizable results. This attribute enhances its utility as a parameter for distinguishing between patients with glomerular hematuria (GH) and those with non-GH.
尿红细胞(RBC)分布(URD)的临床应用价值仍然有限。本研究旨在通过一项多中心研究比较URD和畸形红细胞(dRBC)的诊断性能。
本研究纳入了703名前往韩国四家三级医疗中心就诊的患者。患者被分为经活检确诊的肾小球疾病组(N = 169)、包括慢性肾脏病在内的肾脏疾病组(N = 194)、肾病综合征(NS;N = 88)、肾小管间质疾病组(N = 36)、急性肾损伤组(N = 32)、其他疾病组(N = 10)以及肾外疾病组(N = 174)。进行了肾脏参数、尿液显微镜检查、尿液分析和URD评估。评估了dRBC和URD的诊断性能。
肾小球疾病患者的dRBC和URD中位数均显著升高。URD与dRBC(r = 0.536)和白蛋白肌酐比值(r = 0.186)呈显著相关,而与比重(r = -0.03)无显著相关性。在肾脏疾病中,NS患者的dRBC和URD值明显更高。dRBC和URD结果的一致率为78.3%(112/143),有31例结果不一致。比较肾小球疾病和肾外疾病的ROC曲线分析得出,dRBC的截断值为18%,URD的截断值为31.9%,相应的曲线下面积(AUC)分别为0.79和0.83。
URD表现出相当的诊断性能,其AUC值与dRBC相似,同时还具有提供客观和标准化结果的额外优势。这一特性增强了其作为区分肾小球性血尿(GH)患者和非GH患者的参数的效用。